Discovery of MK-1439, an orally bioavailable non-nucleoside reverse transcriptase inhibitor potent against a wide range of resistant mutant HIV viruses

✍ Scribed by Côté, Bernard; Burch, Jason D.; Asante-Appiah, Ernest; Bayly, Chris; Bédard, Leanne; Blouin, Marc; Campeau, Louis-Charles; Cauchon, Elizabeth; Chan, Manuel; Chefson, Amandine; Coulombe, Nathalie; Cromlish, Wanda; Debnath, Smita; Deschênes, Denis; Dupont-Gaudet, Kristina; Falgueyret, Jean-Pierre; Forget, Robert; Gagné, Sébastien; Gauvreau, Danny; Girardin, Melina; Guiral, Sébastien; Langlois, Eric; Li, Chun Sing; Nguyen, Natalie; Papp, Rob; Plamondon, Serge; Roy, Amélie; Roy, Stéphanie; Seliniotakis, Ria; St-Onge, Miguel; Ouellet, Stéphane; Tawa, Paul; Truchon, Jean-François; Vacca, Joe; Wrona, Marc; Yan, Youwei; Ducharme, Yves

• Book ID: 121432962
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 736 KB
• Volume: 24
• Category: Article
• ISSN: 0960-894X
• DOI: 10.1016/j.bmcl.2013.12.070